Ferric Carboxymaltose Injection: Uses, Dosage, Price & Side Effects Explained

Aug 06, 2025

Introduction

Ferric carboxymaltose injection is a modern intravenous (IV) iron replacement therapy used to treat iron deficiency and iron deficiency anemia, especially when oral iron supplements are ineffective or not tolerated. RUDIX FCM IV is a high-quality injectable formulation that contains ferric carboxymaltose injection 500mg/10ml per vial. It delivers iron directly into the bloodstream, ensuring faster correction of iron levels and improved patient outcomes.

Composition

  • Brand Name: RUDIX FCM IV

  • Active Ingredient: Ferric Carboxymaltose – 500 mg

  • Strength: 500 mg iron / 10 ml solution

  • Route of Administration: Intravenous (IV) use only

  • Form: Injection in vial

What is Ferric Carboxymaltose Injection?

Ferric carboxymaltose injection is an iron-carbohydrate complex that allows a high dose of iron to be administered intravenously in a single sitting. It is designed to replenish iron stores rapidly and safely, bypassing gastrointestinal absorption issues seen with oral iron.

Ferric Carboxymaltose Injection Uses

This injection is prescribed for:

 1. Iron Deficiency Anemia (IDA):

For patients with confirmed iron deficiency who are intolerant or unresponsive to oral iron supplements.

 2. Chronic Kidney Disease (CKD):

Helps maintain hemoglobin levels in patients with non-dialysis and dialysis-dependent kidney conditions.

 3. Postpartum Iron Deficiency:

Used to correct iron loss due to childbirth, especially when hemoglobin levels drop significantly.

 4. Heavy Menstrual Bleeding:

In women with significant blood loss leading to anemia.

 5. Inflammatory Bowel Disease (IBD):

Used when intestinal absorption of oral iron is impaired due to conditions like Crohn's disease or ulcerative colitis.

 6. Pre-Operative Anemia Correction:

To build iron levels before major surgery and reduce the need for blood transfusion.

Ferric Carboxymaltose Injection Dose

Dosage depends on individual iron requirements, body weight, and hemoglobin level. A typical dose:

  • Adults (≥50 kg body weight): Up to 1000 mg of iron (i.e., 2 vials of 500 mg) can be administered in a single sitting.

  • Administration Time: Given as an IV infusion over 15–30 minutes or slow IV push.

  • Repeat Dose: May be repeated after 1 week if necessary.

Important: Dosage should be calculated using a validated iron deficit formula and administered by a healthcare professional.

Ferric Carboxymaltose Injection Price (India)

  • Approximate Price: ₹2,765 – ₹3,950 per 10 ml vial (500 mg)

  • Cost May Vary: Depending on brand, region, and hospital/clinic charges.

  • RUDIX FCM IV by Steris Healthcare Pvt. Ltd. offers quality at competitive pricing with pan-India availability.

Benefits of Ferric Carboxymaltose Injection

  • Delivers a large iron dose in a single administration

  • Rapid replenishment of iron stores and improvement in hemoglobin

  • Lower incidence of gastrointestinal side effects vs oral iron

  • Convenient and suitable for patients with absorption disorders

  • Effective in chronic diseases with ongoing iron loss

Side Effects of Ferric Carboxymaltose Injection

Although generally well-tolerated, some patients may experience:

  • Nausea or vomiting

  • Dizziness or headache

  • Injection site reactions (pain, swelling)

  • Skin rash or itching

  • Hypersensitivity or anaphylactic reactions (rare)

  • Low phosphate levels (transient hypophosphatemia)

Patients must be monitored for at least 30 minutes after the injection for any allergic reactions.

Precautions & Warnings

  • Use only under medical supervision

  • Not recommended during first trimester of pregnancy unless clearly needed

  • Use with caution in patients with liver disorders or chronic infections

  • Avoid repeated high doses too frequently

  • Inform your doctor if you’re taking iron supplements, ACE inhibitors, or have a history of allergic reactions

Why Choose RUDIX FCM IV from Steris Healthcare Pvt. Ltd.?

  •  High-Purity Formulation: Contains clinically approved ferric carboxymaltose injection 500mg/10ml

  •  WHO-GMP Certified Manufacturing

  •  Safe & Effective Iron Correction Therapy

  •  Reliable Nationwide Distribution

  •  Trusted by Doctors, Preferred by Hospitals

  •  Affordable Pricing without compromising quality

FAQs About Ferric Carboxymaltose Injection

Q1. What is ferric carboxymaltose injection used for?

Ans: It is used to treat iron deficiency anemia, especially in patients who cannot tolerate or do not respond to oral iron therapy.

Q2. How is ferric carboxymaltose injection given?

Ans: It is administered intravenously (IV) as a slow injection or infusion over 15–30 minutes in a hospital or clinic setting.

Q3. How many doses are required?

Ans: Often, one or two doses are enough to replenish iron stores, depending on the patient’s hemoglobin level and iron requirement.

Q4. How fast does it work?

Ans: Hemoglobin levels usually begin improving within 1–2 weeks after administration. Full correction may take a few weeks.

Q5. Is ferric carboxymaltose injection safe during pregnancy?

Ans: It is generally considered safe in the second and third trimesters under medical supervision. Not advised in the first trimester.

Q6. Can I take oral iron along with this injection?

Ans: It is usually not necessary. Iron stores are replenished quickly via injection, and combining with oral iron may cause excess.

Q7. What should I do if I feel dizzy or weak after injection?

Ans: Sit or lie down and inform your healthcare provider immediately. Such effects are temporary and manageable under supervision.

Conclusion

Ferric carboxymaltose injection offers a fast, effective, and convenient solution for treating iron deficiency anemia in a variety of patient conditions. RUDIX FCM IV by Steris Healthcare Pvt. Ltd. delivers trusted quality, high efficacy, and affordability in every vial of ferric carboxymaltose injection 500mg/10ml. If you’re seeking quick correction of anemia without the discomfort of oral iron, consult your doctor about RUDIX FCM IV today.

SHARE WITH